Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

47.83
Delayed Data
As of Sep 27
 +0.51 / +1.08%
Today’s Change
40.67
Today|||52-Week Range
68.00
+3.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$8.1B

Company Description

Dr. Reddy's Laboratories Ltd. engages in the manufacture and market of pharmaceutical products. It operates through the following segments: Pharmaceutical Services and Active Ingredient; Global Generics; and Proprietary Products. The Pharmaceutical Services and Active Ingredients segments includes active pharmaceutical ingredients and intermediaries also known as active pharmaceutical products or bulk drug; it also provides research services. The Global Generics segment consists of finished pharmaceutical products ready for consumption. The Proprietary Products segment involves the discovery of new chemical entities for subsequent commercialization and out-licensing. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Contact Information

Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337
Hyderabad Telangana 500034
P:914049002900
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gunupati Venkateswara PrasadCo-Chairman, Chief Executive Officer & MD
Saumen ChakrabortyPresident, CFO & Global Head-IT
Abhijit MukherjeeChief Operating Officer
Sandeep PoddarSecretary & Compliance Officer
M. V. RamanaEVP, Head-Emerging Markets & Global Generics